myvisajobs.com

Home > Visa Sponsor > Bioverativ Therapeutics Inc. - Report

Bioverativ Therapeutics Inc. visa:23 rank:9213
Follow | Edit or Claim
225 Second Avenue Waltham, MA 2451Alert: One LC denied or withdrawn!
  1. Report
  2. Contact
  3. Visa
  4. Salary
  5. Occupation
  6. Location
  7. Review
Bioverativ Therapeutics Inc. has filed 18 labor condition applications for H1B visa and 5 labor certifications for green card from fiscal year 2020 to 2022. Bioverativ Therapeutics was ranked 9213 among all visa sponsors. Please note that 1 LCA for H1B Visa and 0 LC for green card have been denied or withdrawn during the same period.
Contact(edit) NameJob TitlePhoneEmail
LCA for H1B VisaJanet D'ErricoUs Immigration Manager+1617685 xxxx xxxx @sanofi.com
LC for Green CardJanet L Derrico-781-663- xxxxxxxx @sanofi.com
sign in to view all contacts
H1B VisaSalaryCertifiedCertified-Withdrawn(?) DeniedWithdrawn
2024 search 2024 new filings
2023$128,0495101
2022$95,2351300
2021$129,8144300
Green CardSalaryCertifiedCertified-ExpiredDeniedWithdrawn
2024 search 2024 new filings
2023$92,3571100
2022$135,7000100
2021$120,8622000
Willful Violator:No  (?) H1B Dependent:No  (?)
Economic Sector:n.a.
NAICS Industry:Pharmaceutical and Medicine Manufacturing

Green Card Applicant Profile:
Citizenship:India(5)
Class of Admission:H-1B(5)
Degree:Master's(5)
College:University Of Hyderabad(1); The University Of Texas At Tyler(1); The University Of Greenwich(1); Northeastern University(1); North Carolina State University(1)
Major:Pharmaceutical Sciences(1); Computer Science(1); Computer Engineering(1); Biotechnology(1); Biomedical Engineering(1)

Job Locations and Occupation:
Hot H1B Job Locations:Waltham,MA(12) Cambridge,MA(6) ,
Hot H1B Visa Jobs:Senior Associate Scientist, Rare Blood Disorders(3) Senior Associate, Statistical Programming(2) Global Supply Network Planner & Analytics(2) Senior Associate Scientist(2) Scientist, Complement Research(2)
Hot Green Card Jobs:Senior Specialist Trial Supply Operations(1) Senior Associate, Statistical Programming(1) Senior Associate Scientist(1) It Lead(1) Associate Scientist(1)

Hot H1B Occupations:Biochemists and Biophysicists(7) Operations Research Analysts(2) Supply Chain Managers(2) Statisticians(2) Regulatory Affairs Managers(1)
Hot Green Card Occupations:Biochemists And Biophysicists(2) Supply Chain Managers(1) Statisticians(1) Computer Systems Analysts(1)


Note: Before Bioverativ Therapeutics Inc. can hire foreign workers permanently or temporarily, it must file labor certifications with the Department of Labor(DOL), demonstrating that it is paying the required wage for the positions in the geographic region where the jobs are located. Above table reports Labor Condition Application(LCA) for H1B visa and Labor Certification(LC) for green card filed by Bioverativ Therapeutics Inc.. The data only indicates the number of applications filed by Bioverativ Therapeutics Inc.. It does not mean that Bioverativ Therapeutics Inc. actually got the visa and hired the workers.

Our LCA data includes LCA submitted for not only new employment, but also continuation or change in previously approved employment, new concurrent employment, change in employer and amended petition. Usually, only LCA for new employment needs H1B Visa quota if it is not cap-exempt.

Bioverativ Therapeutics Inc. has applied for 23 LC and LCA from fiscal year 2021 to 2023. But this does not mean they really hired 23 foreign workers during this period. The visa applications might have been denied. When an employee renews or transfers his H1B visa or change work location under some circumstances, he will also file a new LCA application.

Department of Labor(DOL) typically certifies more than 3 times the number of foreign work requests than the number of H1B visas issued by USCIS. So there is no one to one relationship between the number of workers certified by the DOL and the number of H1B work visas issued by the United States Citizenship and Immigration Services (USCIS).


Green Card | H1B Visa | Work Visa | About Us | Contact Us | FAQ | Visa Reports

Copyright © 2006 - 2024